Stem Cell Research Tools in Human Metabolic Disorders: An Overview.
Serena RicciPietro CacialliPublished in: Cells (2021)
Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge economic hit and tension for society. In this review, we recapitulate the recent advancements in stem cell (gene) therapy as potential tools for the long-term treatment of both inherited (lysosomal storage diseases) and acquired (diabetes mellitus, obesity) metabolic disorders, focusing on the main promising results observed in human patients and discussing the critical hurdles preventing the definitive jump of this approach from the bench to the clinic.
Keyphrases
- stem cells
- endothelial cells
- gene therapy
- end stage renal disease
- healthcare
- ejection fraction
- type diabetes
- public health
- newly diagnosed
- induced pluripotent stem cells
- metabolic syndrome
- chronic kidney disease
- mental health
- squamous cell carcinoma
- weight gain
- human health
- risk assessment
- patient reported outcomes
- rectal cancer
- glycemic control
- physical activity
- smoking cessation